Given the growing interest in potentiators of AMPA-mediated glutamatergic signaling in the treatment of depression (also known as ampakines) [41] [42] [43], we investigated the relationship between GR blockage and AMPA receptor expression in different populations of hippocampal newborn neurons. This evidence concerns the gene NR3C1 and depressive symptom measurement.